Raymond James & Associates Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Call Options

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2020 Nov 04, 2020	SELL	$103.87 - $120.36 $270,062 - $312,936	-2,600 Reduced 6.13%	39,800 $1.02 Million
Q1 2020 Apr 21, 2020	BUY	$65.95 - $98.35 $6,595 - $9,835	100 Added 0.24%	42,400 $70,000
Q4 2019 Feb 12, 2020	SELL	$74.65 - $98.46 $29,860 - $39,384	-400 Reduced 0.94%	42,300 $453,000
Q2 2019 Aug 06, 2019	BUY	N/A	1,200 Added 2.89%	42,700 $109,000
Q1 2019 May 06, 2019	SELL	N/A	-500 Reduced 1.19%	41,500 $297,000
Q4 2018 Feb 11, 2019	BUY	N/A	900 Added 2.19%	42,000 $15,000
Q3 2018 Nov 14, 2018	BUY	N/A	200 Added 0.49%	41,100 $709,000
Q2 2018 Aug 14, 2018	SELL	N/A	-900 Reduced 2.15%	40,900 $658,000
Q1 2018 May 14, 2018	SELL	N/A	-12,400 Reduced 22.88%	41,800 $520,000
Q4 2017 Feb 14, 2018	SELL	N/A	-11,100 Reduced 17.0%	54,200 $463,000
Q3 2017 Nov 13, 2017	BUY	N/A	10,100 Added 18.3%	65,300 $601,000
Q2 2017 Aug 14, 2017	BUY	N/A	55,200	55,200 $247,000

Others Institutions Holding XBI

# of Institutions

882

Shares Held

107M

Call Options Held

26.2M

Put Options Held

37.6M

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.